Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000431

Type of data: NGS (Target Capture)
Access criteria: Controlled-access (Type I)
Total data volume: 1.0 TB
File formats: FASTQ
Research: hum0293
Date published: 2022-07-25
Date modified: 2022-07-25
DDBJ Search: JGAD000431 (opens in a new tab)
JGA Study: JGAS000320 (opens in a new tab)

Analysis method

WGS

Materials and participants: ATL (ICD10: C91.5): 7 cases
ATL cell line (TL-om1 cell): 1 sample (12 genetic modifications); Health status
Affected
Subject count
8 (Mixed)
Disease: ATL (C915)
Sample description: DNAs extracted from peripheral blood mononuclear cells of primary ATL patients or genetic modified ATL cell line (TL-om1 cell); Tissue
PBMC, Peripheral blood
Tumor / normal
Tumor
Cell line: TL-Om1
Sample provider: N/A
Experimental method: WGS
Target: N/A
Fragmentation: BGI's standard protocol
Platform: BGI BGISEQ-500
Illumina HiSeq X
Read type: Paired-end
Read length: 150 bp
Data use policy: NBDC data sharing policy (JGAP000001)